Neuroone Medical Technologies Corp
NASDAQ:NMTC
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Price:
1.12 USD
-3.45%
Market Closed
Updated:
May 13, 2024
P/OCF
Price to OCF
Price to OCF
-2.1
Current
-2.8
Median
15.6
Industry
Higher
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-2.1
Market Cap
/
27.8m
Operating Cash Flow
-13.2m
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
27.8m USD | -2.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 25.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 80.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 36.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.1B USD | 17 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 43.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 19.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 24.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 58.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.8B CNY | 29.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 62.7 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
